Kyung Nam Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May '26 May 28, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	34,228	62,596	59,868	82,676	88,518	140,585
Market Cap Growth	-29.24%	4.56%	-27.59%	-6.60%	-37.04%	-17.15%
Enterprise Value	35,139	69,553	82,641	73,133	109,068	157,440
Last Close Price	2190.00	4005.00	6728.67	10721.07	15611.41	28500.11
PE Ratio	3.56	6.21	-	-	-	-
Forward PE	-	12.72	12.72	12.72	12.72	12.72
PS Ratio	0.61	1.03	1.01	1.40	1.37	1.98
PB Ratio	0.30	0.54	0.67	0.88	1.22	2.45
P/TBV Ratio	0.30	0.55	0.86	0.89	1.24	2.48
P/OCF Ratio	56.96	34.05	86.35	1155.05	-	53.76
EV/Sales Ratio	0.63	1.14	1.39	1.24	1.69	2.22
EV/EBITDA Ratio	12.91	31.16	-	-	-	38.38
EV/EBIT Ratio	52.83	-	-	-	-	61.11
Debt / Equity Ratio	0.32	0.33	0.57	0.35	0.55	0.72
Debt / EBITDA Ratio	13.37	16.84	-	-	-	10.09
Net Debt / Equity Ratio	-0.08	-0.11	0.18	-0.13	0.22	0.24
Net Debt / EBITDA Ratio	-3.26	-5.93	-22.07	8.47	-2.35	3.39
Net Debt / FCF Ratio	1.33	2.84	-1.01	4.42	-1.40	-0.32
Asset Turnover	0.35	0.37	0.39	0.45	0.51	0.71
Inventory Turnover	3.11	3.39	3.07	3.21	3.69	4.39
Quick Ratio	1.43	1.41	0.81	1.35	1.56	1.22
Current Ratio	1.76	1.68	1.03	1.70	2.16	1.49
Return on Equity (ROE)	-3.29%	-3.98%	-10.42%	-9.41%	-4.94%	-8.66%
Return on Assets (ROA)	0.24%	-0.09%	-1.47%	-1.62%	-4.34%	1.60%
Return on Invested Capital (ROIC)	0.59%	-0.23%	-3.84%	-4.01%	-10.94%	4.70%
Return on Capital Employed (ROCE)	0.50%	-0.20%	-3.60%	-3.60%	-8.80%	2.90%
Earnings Yield	28.07%	16.10%	-35.07%	-9.47%	-3.86%	-3.90%
FCF Yield	-19.18%	-7.43%	-26.94%	-3.36%	-13.16%	-30.56%
Buyback Yield / Dilution	-52.38%	-22.60%	-21.50%	-27.71%	-32.46%	-11.06%